Industry: Food & Beverages
Published Date: 2025-11-28
Pages: 118 Pages
Report ld: 4338406
Request Sample
Customized Report
Milk Infant Formula Market Size(US$)

CAGR 2025-2031
3.1%
Market Size,2031
USD 36,746
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Milk Infant Formula was valued at US$ 29752 million in the year 2024 and is projected to reach a revised size of US$ 36746 million by 2031, growing at a CAGR of 3.1% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Milk Infant Formula competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Milk Infant Formula production reached approximately 2,118.51 K MT, with an average global market price of around US$ 14,200 per MT.
Milk Infant Formula is a specially designed powdered formula food for infants, intended to partially or completely replace breast milk when needed. It is typically based on cow’s milk or other dairy proteins, with carefully adjusted levels of fats, carbohydrates, vitamins, minerals and essential micronutrients to meet the nutritional requirements of early growth and development. Produced under strict food safety and regulatory standards, infant formula must be registered or approved by competent authorities, ensuring its composition is safe, digestible and nutritionally appropriate, and providing a consistent, controllable source of nutrition for babies who cannot be exclusively breastfed or require formula feeding.
From a supply chain perspective, the Milk Infant Formula industry can be broadly divided into three layers: upstream raw material and packaging suppliers, midstream formula development and manufacturing, and downstream distribution and end-market service. Upstream players provide fresh raw milk, skimmed milk powder, whey powder, lactose, vegetable oils, whey protein concentrates, vitamin–mineral premixes and other nutritional ingredients, along with cans, lids, composite films and labels for packaging; major global dairy groups typically combine owned and contracted farms with a global network of base powder and ingredient plants to secure high-quality milk and hedge regional and price volatility risks. Midstream is dominated by brand owners and their owned or contract factories, which handle formula design, raw-material qualification, spray-drying and blending, canning and nitrogen flushing, and finished-product testing under stringent regulatory oversight. In markets such as China, the EU and the U.S., authorities use recipe registration, tighter control of base powder and auxiliary materials, and on-site inspections to keep infant formula within a highly controlled quality and safety framework, raising both production and compliance barriers. Downstream, regional distributors, mother-and-baby specialty chains, supermarkets, e-commerce and cross-border platforms, as well as hospitals and pharmacies, form the main go-to-market channels, while in some countries government procurement and welfare programs are among the largest single buyers, reinforcing the dominance of a few large suppliers. Analyses of the 2022 U.S. infant formula shortage by regulators and national academies have highlighted how high concentration in a handful of plants and brands, dependence on specific ingredient and packaging vendors, and limited visibility along the chain amplified the impact of individual plant shutdowns, prompting the industry and policymakers to focus on capacity redundancy, diversified sourcing, better inventory strategies and more resilient, information-rich distribution networks.
Market Development Opportunities & Main Driving FactorsGlobally, the Milk Infant Formula market continues to show solid growth, supported by ongoing urbanization, a rising share of working mothers and growing awareness of the “first 1,000 days” as a critical nutrition window. Leading players report that infant nutrition businesses are delivering mid- to high single-digit growth, with premium offerings such as formulas enriched with Human Milk Oligosaccharides (HMOs), prebiotics, organic and A2 variants driving mix upgrade and margin expansion. In emerging markets, infant formula remains central to improving early-life nutrition, with multinational and local brands expanding reach through differentiated formulations, strong presence in mother-and-baby specialty stores and increasing e-commerce penetration. At the same time, a number of governments facing declining birth rates are introducing childcare subsidies and even free-milk initiatives, which help ease the cost of raising children and support medium- to long-term demand expectations for infant nutrition categories.
Market Challenges, Risks, & RestraintsThe industry also faces structural headwinds related to demographics, regulation and competition. In many developed economies and in key markets such as China, the number of newborns has been trending down, putting pressure on baseline demand for standard formulas, and several companies have publicly acknowledged volume declines in their China infant formula business. Meanwhile, regulators are tightening rules on formula registration, on-pack claims, cross-border trade and quality control, pushing formulations toward simplification while raising R&D and compliance costs. Any safety incident or recall can quickly escalate into a serious brand and channel crisis. Competitive intensity remains high, with global giants, strong domestic champions and regional brands all vying for share in organic, premium and specialized segments. Price warfare and aggressive promotions still occur, and the high transparency of online pricing further squeezes margins, especially for mid- and low-tier brands.
Downstream Demand TrendsOn the demand side, the market is characterized by relatively stable or slowing volumes but clear value-mix upgrading. Even as birth numbers soften, parents are willing to spend more per child on safety and science-backed nutrition, accelerating the shift toward premium, organic, A2, HMO/prebiotic-enriched and specialized medical formulas, which are capturing a growing share of category value. Channel dynamics are also evolving: offline mother-and-baby specialty chains remain critical for brand building and professional advisory services, while e-commerce, direct-to-consumer stores and cross-border platforms continue to gain share, with live-streaming and large online campaigns becoming key tools for consumer education and acquisition. Regionally, China is going through a period of destocking and structural adjustment toward more premium and differentiated offerings, while fast-growing Asian, Middle Eastern, African and Latin American markets are contributing incremental volume and value. Looking ahead, companies that can combine rigorous safety and traceability with credible nutrition science, sustainability and truly omnichannel engagement with new-generation parents will be best positioned to build durable competitive advantages in the Milk Infant Formula market.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Milk Infant Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Milk Infant Formula.
The Milk Infant Formula market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Milk Infant Formula market comprehensively. Regional market sizes, concerning products by Type, by Sales Channel, by Stage and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Milk Infant Formula manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sales Channel, by Stage and by regions.
By Company
Danone
Nestle
Abbott
Reckiit
Biostime
Bellamy
Topfer
HiPP
Perrigo
Humana
Nutribio
Meiji
a2 Milk
Ausnutria
Feihe
Yili
Yashili
Bright Dairy & Food
Junlebao
Beingmate
Wonder Sun
Wissun
YeePer
Synutra
Mengniu Dairy
Holle
Nestle
Segment by Type
Cow Milk Powder
Goat Milk Powder
Other
Segment by Stage
First Stage
Second Stage
Third Stage
Segment by Source
Regular
Organic
Segment by Price Range
Economy Type
Mid-range Type
High-end Type
Segment by Sales Channel
Maternal Stores
Supermarkets/Hypermarkets
Online Retail
Others
Consumption by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Milk Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Milk Infant Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Milk Infant Formula Market Overview
1.1 Product Definition
1.2 Milk Infant Formula by Type
1.2.1 Global Milk Infant Formula Market Value Comparison by Type (2024 VS 2031)
1.2.2 Cow Milk Powder
1.2.3 Goat Milk Powder
1.2.4 Other
1.3 Milk Infant Formula by Stage
1.3.1 Global Milk Infant Formula Market Value Comparison by Stage: 2024 VS 2031
1.3.2 First Stage
1.3.3 Second Stage
1.3.4 Third Stage
1.4 Milk Infant Formula by Source
1.4.1 Global Milk Infant Formula Market Value Comparison by Source: 2024 VS 2031
1.4.2 Regular
1.4.3 Organic
1.5 Milk Infant Formula by Price Range
1.5.1 Global Milk Infant Formula Market Value Comparison by Price Range: 2024 VS 2031
1.5.2 Economy Type
1.5.3 Mid-range Type
1.5.4 High-end Type
1.6 Milk Infant Formula by Sales Channel
1.6.1 Global Milk Infant Formula Market Value by Sales Channel (2024 VS 2031)
1.6.2 Maternal Stores
1.6.3 Supermarkets/Hypermarkets
1.6.4 Online Retail
1.6.5 Others
1.7 Global Milk Infant Formula Market Size Estimates and Forecasts
1.7.1 Global Milk Infant Formula Revenue 2020-2031
1.7.2 Global Milk Infant Formula Sales 2020-2031
1.7.3 Global Milk Infant Formula Market Average Price (2020-2031)
1.8 Assumptions and Limitations
2 Milk Infant Formula Market Competition by Manufacturers
2.1 Global Milk Infant Formula Sales Market Share by Manufacturers (2020-2025)
2.2 Global Milk Infant Formula Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Milk Infant Formula Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Milk Infant Formula, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Milk Infant Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Milk Infant Formula, Product Type & Application
2.7 Global Key Manufacturers of Milk Infant Formula, Date of Enter into This Industry
2.8 Global Milk Infant Formula Market Competitive Situation and Trends
2.8.1 Global Milk Infant Formula Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Milk Infant Formula Players Market Share by Revenue
2.8.3 Global Milk Infant Formula Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Milk Infant Formula Market Scenario by Region
3.1 Global Milk Infant Formula Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Milk Infant Formula Sales by Region: 2020-2031
3.2.1 Global Milk Infant Formula Sales by Region: 2020-2025
3.2.2 Global Milk Infant Formula Sales by Region: 2026-2031
3.3 Global Milk Infant Formula Revenue by Region: 2020-2031
3.3.1 Global Milk Infant Formula Revenue by Region: 2020-2025
3.3.2 Global Milk Infant Formula Revenue by Region: 2026-2031
3.4 North America Milk Infant Formula Market Facts & Figures by Country
3.4.1 North America Milk Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Milk Infant Formula Sales by Country (2020-2031)
3.4.3 North America Milk Infant Formula Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Milk Infant Formula Market Facts & Figures by Country
3.5.1 Europe Milk Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Milk Infant Formula Sales by Country (2020-2031)
3.5.3 Europe Milk Infant Formula Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Milk Infant Formula Market Facts & Figures by Region
3.6.1 Asia Pacific Milk Infant Formula Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Milk Infant Formula Sales by Region (2020-2031)
3.6.3 Asia Pacific Milk Infant Formula Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Milk Infant Formula Market Facts & Figures by Country
3.7.1 Latin America Milk Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Milk Infant Formula Sales by Country (2020-2031)
3.7.3 Latin America Milk Infant Formula Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Milk Infant Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa Milk Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Milk Infant Formula Sales by Country (2020-2031)
3.8.3 Middle East and Africa Milk Infant Formula Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Milk Infant Formula Sales by Type (2020-2031)
4.1.1 Global Milk Infant Formula Sales by Type (2020-2025)
4.1.2 Global Milk Infant Formula Sales by Type (2026-2031)
4.1.3 Global Milk Infant Formula Sales Market Share by Type (2020-2031)
4.2 Global Milk Infant Formula Revenue by Type (2020-2031)
4.2.1 Global Milk Infant Formula Revenue by Type (2020-2025)
4.2.2 Global Milk Infant Formula Revenue by Type (2026-2031)
4.2.3 Global Milk Infant Formula Revenue Market Share by Type (2020-2031)
4.3 Global Milk Infant Formula Price by Type (2020-2031)
5 Segment by Sales Channel
5.1 Global Milk Infant Formula Sales by Sales Channel (2020-2031)
5.1.1 Global Milk Infant Formula Sales by Sales Channel (2020-2025)
5.1.2 Global Milk Infant Formula Sales by Sales Channel (2026-2031)
5.1.3 Global Milk Infant Formula Sales Market Share by Sales Channel (2020-2031)
5.2 Global Milk Infant Formula Revenue by Sales Channel (2020-2031)
5.2.1 Global Milk Infant Formula Revenue by Sales Channel (2020-2025)
5.2.2 Global Milk Infant Formula Revenue by Sales Channel (2026-2031)
5.2.3 Global Milk Infant Formula Revenue Market Share by Sales Channel (2020-2031)
5.3 Global Milk Infant Formula Price by Sales Channel (2020-2031)
6 Key Companies Profiled
6.1 Danone
6.1.1 Danone Company Information
6.1.2 Danone Description and Business Overview
6.1.3 Danone Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Danone Milk Infant Formula Product Portfolio
6.1.5 Danone Recent Developments/Updates
6.2 Nestle
6.2.1 Nestle Company Information
6.2.2 Nestle Description and Business Overview
6.2.3 Nestle Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Nestle Milk Infant Formula Product Portfolio
6.2.5 Nestle Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Milk Infant Formula Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Reckiit
6.4.1 Reckiit Company Information
6.4.2 Reckiit Description and Business Overview
6.4.3 Reckiit Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Reckiit Milk Infant Formula Product Portfolio
6.4.5 Reckiit Recent Developments/Updates
6.5 Biostime
6.5.1 Biostime Company Information
6.5.2 Biostime Description and Business Overview
6.5.3 Biostime Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biostime Milk Infant Formula Product Portfolio
6.5.5 Biostime Recent Developments/Updates
6.6 Bellamy
6.6.1 Bellamy Company Information
6.6.2 Bellamy Description and Business Overview
6.6.3 Bellamy Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bellamy Milk Infant Formula Product Portfolio
6.6.5 Bellamy Recent Developments/Updates
6.7 Topfer
6.7.1 Topfer Company Information
6.7.2 Topfer Description and Business Overview
6.7.3 Topfer Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Topfer Milk Infant Formula Product Portfolio
6.7.5 Topfer Recent Developments/Updates
6.8 HiPP
6.8.1 HiPP Company Information
6.8.2 HiPP Description and Business Overview
6.8.3 HiPP Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.8.4 HiPP Milk Infant Formula Product Portfolio
6.8.5 HiPP Recent Developments/Updates
6.9 Perrigo
6.9.1 Perrigo Company Information
6.9.2 Perrigo Description and Business Overview
6.9.3 Perrigo Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Perrigo Milk Infant Formula Product Portfolio
6.9.5 Perrigo Recent Developments/Updates
6.10 Humana
6.10.1 Humana Company Information
6.10.2 Humana Description and Business Overview
6.10.3 Humana Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Humana Milk Infant Formula Product Portfolio
6.10.5 Humana Recent Developments/Updates
6.11 Nutribio
6.11.1 Nutribio Company Information
6.11.2 Nutribio Description and Business Overview
6.11.3 Nutribio Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nutribio Milk Infant Formula Product Portfolio
6.11.5 Nutribio Recent Developments/Updates
6.12 Meiji
6.12.1 Meiji Company Information
6.12.2 Meiji Description and Business Overview
6.12.3 Meiji Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Meiji Milk Infant Formula Product Portfolio
6.12.5 Meiji Recent Developments/Updates
6.13 a2 Milk
6.13.1 a2 Milk Company Information
6.13.2 a2 Milk Description and Business Overview
6.13.3 a2 Milk Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.13.4 a2 Milk Milk Infant Formula Product Portfolio
6.13.5 a2 Milk Recent Developments/Updates
6.14 Ausnutria
6.14.1 Ausnutria Company Information
6.14.2 Ausnutria Description and Business Overview
6.14.3 Ausnutria Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Ausnutria Milk Infant Formula Product Portfolio
6.14.5 Ausnutria Recent Developments/Updates
6.15 Feihe
6.15.1 Feihe Company Information
6.15.2 Feihe Description and Business Overview
6.15.3 Feihe Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Feihe Milk Infant Formula Product Portfolio
6.15.5 Feihe Recent Developments/Updates
6.16 Yili
6.16.1 Yili Company Information
6.16.2 Yili Description and Business Overview
6.16.3 Yili Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Yili Milk Infant Formula Product Portfolio
6.16.5 Yili Recent Developments/Updates
6.17 Yashili
6.17.1 Yashili Company Information
6.17.2 Yashili Description and Business Overview
6.17.3 Yashili Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Yashili Milk Infant Formula Product Portfolio
6.17.5 Yashili Recent Developments/Updates
6.18 Bright Dairy & Food
6.18.1 Bright Dairy & Food Company Information
6.18.2 Bright Dairy & Food Description and Business Overview
6.18.3 Bright Dairy & Food Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Bright Dairy & Food Milk Infant Formula Product Portfolio
6.18.5 Bright Dairy & Food Recent Developments/Updates
6.19 Junlebao
6.19.1 Junlebao Company Information
6.19.2 Junlebao Description and Business Overview
6.19.3 Junlebao Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Junlebao Milk Infant Formula Product Portfolio
6.19.5 Junlebao Recent Developments/Updates
6.20 Beingmate
6.20.1 Beingmate Company Information
6.20.2 Beingmate Description and Business Overview
6.20.3 Beingmate Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Beingmate Milk Infant Formula Product Portfolio
6.20.5 Beingmate Recent Developments/Updates
6.21 Wonder Sun
6.21.1 Wonder Sun Company Information
6.21.2 Wonder Sun Description and Business Overview
6.21.3 Wonder Sun Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Wonder Sun Milk Infant Formula Product Portfolio
6.21.5 Wonder Sun Recent Developments/Updates
6.22 Wissun
6.22.1 Wissun Company Information
6.22.2 Wissun Description and Business Overview
6.22.3 Wissun Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Wissun Milk Infant Formula Product Portfolio
6.22.5 Wissun Recent Developments/Updates
6.23 YeePer
6.23.1 YeePer Company Information
6.23.2 YeePer Description and Business Overview
6.23.3 YeePer Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.23.4 YeePer Milk Infant Formula Product Portfolio
6.23.5 YeePer Recent Developments/Updates
6.24 Synutra
6.24.1 Synutra Company Information
6.24.2 Synutra Description and Business Overview
6.24.3 Synutra Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Synutra Milk Infant Formula Product Portfolio
6.24.5 Synutra Recent Developments/Updates
6.25 Mengniu Dairy
6.25.1 Mengniu Dairy Company Information
6.25.2 Mengniu Dairy Description and Business Overview
6.25.3 Mengniu Dairy Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Mengniu Dairy Milk Infant Formula Product Portfolio
6.25.5 Mengniu Dairy Recent Developments/Updates
6.26 Holle
6.26.1 Holle Company Information
6.26.2 Holle Description and Business Overview
6.26.3 Holle Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Holle Milk Infant Formula Product Portfolio
6.26.5 Holle Recent Developments/Updates
6.27 Nestle
6.27.1 Nestle Company Information
6.27.2 Nestle Description and Business Overview
6.27.3 Nestle Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.27.4 Nestle Milk Infant Formula Product Portfolio
6.27.5 Nestle Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Milk Infant Formula Industry Chain Analysis
7.2 Milk Infant Formula Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Milk Infant Formula Production Mode & Process Analysis
7.4 Milk Infant Formula Sales and Marketing
7.4.1 Milk Infant Formula Sales Channels
7.4.2 Milk Infant Formula Distributors
7.5 Milk Infant Formula Customer Analysis
8 Milk Infant Formula Market Dynamics
8.1 Milk Infant Formula Industry Trends
8.2 Milk Infant Formula Market Drivers
8.3 Milk Infant Formula Market Challenges
8.4 Milk Infant Formula Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Milk Infant Formula market size was US$ 30560 million in 2025 and is forecast to reach a readjusted size of US$ 37780 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 121
USD 4250.00
(Single User License)
The global Milk Infant Formula market is projected to grow from US$ 30560 million in 2025 to US$ 37780 million by 2032, at a CAGR of 3.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 214
USD 4900.00
(Single User License)
The global market for Milk Infant Formula was estimated to be worth US$ 30560 million in 2025 and is projected to reach US$ 37780 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 187
USD 3950.00
(Single User License)
The global Milk Infant Formula market was valued at US$ 30560 million in 2025 and is anticipated to reach US$ 37780 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 151
USD 2900.00
(Single User License)
The global market for Milk Infant Formula was estimated to be worth US$ 29752 million in 2024 and is forecast to a readjusted size of US$ 36746 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-11-28
Pages: 183
USD 3950.00
(Single User License)
The global Milk Infant Formula market is projected to grow from US$ 29752 million in 2024 to US$ 36746 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-28
Pages: 209
USD 4900.00
(Single User License)
The global Milk Infant Formula market size was US$ 29752 million in 2024 and is forecast to a readjusted size of US$ 36746 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-11-28
Pages: 128
USD 4250.00
(Single User License)
The global market for Milk Infant Formula was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 168
USD 3950.00
(Single User License)
Milk Infant Formula is usually made from cows' milk that has been treated to make it more suitable for babies.
Published Date: 2024-04-22
Pages: 129
USD 4900.00
(Single User License)
Milk Infant Formula is usually made from cows' milk that has been treated to make it more suitable for babies.
Published Date: 2024-01-24
Pages: 167
USD 3950.00
(Single User License)
The global Milk Infant Formula market size was US$ 30560 million in 2025 and is forecast to reach a readjusted size of US$ 37780 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 121
The global Milk Infant Formula market is projected to grow from US$ 30560 million in 2025 to US$ 37780 million by 2032, at a CAGR of 3.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 214
The global market for Milk Infant Formula was estimated to be worth US$ 30560 million in 2025 and is projected to reach US$ 37780 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-03-05
Pages: 187
The global Milk Infant Formula market was valued at US$ 30560 million in 2025 and is anticipated to reach US$ 37780 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-03-05
Pages: 151
The global market for Milk Infant Formula was estimated to be worth US$ 29752 million in 2024 and is forecast to a readjusted size of US$ 36746 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-11-28
Pages: 183
The global Milk Infant Formula market is projected to grow from US$ 29752 million in 2024 to US$ 36746 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-28
Pages: 209
The global Milk Infant Formula market size was US$ 29752 million in 2024 and is forecast to a readjusted size of US$ 36746 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-11-28
Pages: 128
The global market for Milk Infant Formula was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 168
Milk Infant Formula is usually made from cows' milk that has been treated to make it more suitable for babies.
Published: 2024-04-22
Pages: 129
Milk Infant Formula is usually made from cows' milk that has been treated to make it more suitable for babies.
Published: 2024-01-24
Pages: 167
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now